论文信息 - Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies - 字舞流文

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

A. Shaw | S. Ou | F. de Marinis | L. Crinò | Dong-Wan Kim | S. Gadgeel | A. Dingemans | F. Barlesi | Shiyao Liu | Ravindra Gupta | V. Smoljanović | J. Yang | M. Schulz